SCHEMBL22200742

SCHEMBL22200742

CC(C)n1c(=O)c(-c2ccc(NSCc3ccccc3)c(F)c2)nc2cnc(NC3CCC(N(C)C)C(F)C3)nc21

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ERN1 O75460 6/20 0.49
ALDH1A1 P00352 8/20 0.34
CASP1 P29466 7/20 0.34
HIF1A Q16665 7/20 0.34
HSD17B10 Q99714 7/20 0.34
USP2 O75604 7/20 0.34
CASP7 P55210 6/20 0.34
MEN1 O00255 5/20 0.34
KMT2A Q03164 5/20 0.34
MAPK1 P28482 4/20 0.34
TSHR P16473 3/20 0.34
LMNA P02545 2/20 0.34
RECQL P46063 2/20 0.34
CYP1A2 P05177 8/20 0.34
CYP2D6 P10635 4/20 0.34
CYP3A4 P08684 3/20 0.34
CYP2C9 P11712 2/20 0.34
CYP2C19 P33261 2/20 0.34
CLK4 Q9HAZ1 1/20 0.34
GLA P06280 2/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22200599 0.95 ERN1 (0.51) ERN1ALDH1A1CASP1HIF1AHSD17B10
SCHEMBL22200595 0.89 ERN1 (0.49) ERN1ALDH1A1CASP1HSD17B10CASP7
SCHEMBL25035553 0.88 ERN1 (0.64) ERN1ALDH1A1CASP1HIF1AHSD17B10
SCHEMBL22200490 0.88 ERN1 (0.64) ERN1ALDH1A1CASP1HIF1AHSD17B10
SCHEMBL29357229 0.88 ERN1 (0.64) ERN1ALDH1A1CASP1HIF1AHSD17B10
SCHEMBL22191557 0.88 ERN1 (0.64) ERN1ALDH1A1CASP1HIF1AHSD17B10
SCHEMBL22200381 0.88 ERN1 (0.47) ERN1ALDH1A1CASP1HSD17B10CASP7
SCHEMBL22190947 0.83 ERN1 (0.66) ERN1ALDH1A1CASP1HIF1AHSD17B10
SCHEMBL22200487 0.83 ERN1 (0.66) ERN1ALDH1A1CASP1HIF1AHSD17B10
SCHEMBL22200488 0.83 ERN1 (0.66) ERN1ALDH1A1CASP1HIF1AHSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2020142612-A1 PYRIDO-PYRIMIDINONE AND PTERIDINONE COMPOUNDS AS INHIBITORS OF ENDORIBONUCLEASE INOSITOL REQUIRING ENZYME I (IRE I ALPHA) FOR THE TREATMENT OF CANCER DISEASES. GENENTECH, INC. (US) 2020-07-09 WO disclosed